Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended April 30 , 2021 Commission file number 001-40483 ALZAMEND NEURO , INC . ( Exact name of registrant as specified in its charter ) Delaware ( State or other jurisdiction of incorporation or organization ) 3802 Spectrum Boulevard , Suite 112C , Tampa , FL ( Address of principal executive offices ) 33612 ( Zip Code ) Securities registered under Section 12 ( b ) of the Act : Title of Each Class 81-1822909 ( I.R.S. Employer Identification Number ) ( 844 ) 722-6303 ( Registrant's telephone number , including area code ) Common Stock , $ 0.0001 par value per share Securities registered under Section 12 ( g ) of the Act : None Name of each exchange on which registered NASDAQ Capital Market Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No þ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Exchange Act . Yes No þ Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding year ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No þ " Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes þ No " Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or an emerging growth company . See the definitions of “ large accelerated filer , ” “ accelerated filer , ” “ smaller reporting company , " and " emerging growth company ” in Rule 12b - 2 of the Exchange Act . Large accelerated filer Non - accelerated filer þ Emerging growth company þ Accelerated filer Smaller reporting company þ If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) . Yes¨ No þ The aggregate market value of the common stock held by non - affiliates of the registrant , based on the closing price of the shares of common stock on June 15 , 2021 as reported by The Nasdaq Stock Market LLC on such date was approximately $ 745.1 million . The registrant has elected to use June 15 , 2021 , which was the closing date of its initial public offering of common stock , as the calculation date because on October 31 , 2020 ( the last business day of the registrant's most recently completed second fiscal quarter ) , the registrant was not a publicly traded company . Shares of the registrant's common stock held by each executive officer and director and by each other person